These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 15266617)

  • 1. Endocrine abnormalities in patients with Jacobsen (11q-) syndrome.
    Haghi M; Dewan A; Jones KL; Reitz R; Jones C; Grossfeld P
    Am J Med Genet A; 2004 Aug; 129A(1):62-3. PubMed ID: 15266617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 11q Terminal Deletion Disorder Jacobsen Syndrome is a Syndromic Primary Immunodeficiency.
    Dalm VA; Driessen GJ; Barendregt BH; van Hagen PM; van der Burg M
    J Clin Immunol; 2015 Nov; 35(8):761-8. PubMed ID: 26566921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interstitial deletion of 11q-implicating the KIRREL3 gene in the neurocognitive delay associated with Jacobsen syndrome.
    Guerin A; Stavropoulos DJ; Diab Y; Chénier S; Christensen H; Kahr WH; Babul-Hirji R; Chitayat D
    Am J Med Genet A; 2012 Oct; 158A(10):2551-6. PubMed ID: 22965935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of insulin-like growth factor-1 and insulinlike growth factor binding protein-3 in diagnosis of growth hormone deficiency in short-stature children.
    Ali A; Hashim R; Khan FA; Sattar A; Ijaz A; Manzoor SM; Younas M
    J Ayub Med Coll Abbottabad; 2009; 21(3):40-5. PubMed ID: 20929010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short stature and decreased insulin-like growth factor I (IGF-I)/growth hormone (GH)-ratio in an adult GH-deficient patient pointing to additional partial GH insensitivity due to a R179C mutation of the growth hormone receptor.
    Meyer S; Ipek M; Keth A; Minnemann T; von Mach MA; Weise A; Ittner JR; Nawroth PP; Plöckinger U; Stalla GK; Tuschy U; Weber MM; Kann PH; ;
    Growth Horm IGF Res; 2007 Aug; 17(4):307-14. PubMed ID: 17462934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 11q terminal deletion disorder: a prospective study of 110 cases.
    Grossfeld PD; Mattina T; Lai Z; Favier R; Jones KL; Cotter F; Jones C
    Am J Med Genet A; 2004 Aug; 129A(1):51-61. PubMed ID: 15266616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth hormone/IGF-I axis and growth hormone receptor mutations in idiopathic short stature.
    El Kholy M; Mella P; Rashad M; Buzi F; Meazza C; Zahra S; Elsedfy HH
    Horm Res Paediatr; 2011; 76(5):300-6. PubMed ID: 21846964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SHOX gene variants: growth hormone/insulin-like growth factor-1 status and response to growth hormone treatment.
    Shapiro S; Klein GW; Klein ML; Wallach EJ; Fen Y; Godbold JH; Rapaport R
    Horm Res Paediatr; 2015; 83(1):26-35. PubMed ID: 25659810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Jacobsen syndrome and bipolar affective disorder in a patient with a de novo 11q terminal deletion.
    Böhm D; Hoffmann K; Laccone F; Wilken B; Dechent P; Frahm J; Bartels I; Bohlander SK
    Am J Med Genet A; 2006 Feb; 140(4):378-82. PubMed ID: 16419136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 levels during growth hormone treatment in prepubertal short children born small for gestational age.
    Boguszewski M; Jansson C; Rosberg S; Albertsson-Wikland K
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3902-8. PubMed ID: 8923836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular characterization of an 11q interstitial deletion in a patient with the clinical features of Jacobsen syndrome.
    Wenger SL; Grossfeld PD; Siu BL; Coad JE; Keller FG; Hummel M
    Am J Med Genet A; 2006 Apr; 140(7):704-8. PubMed ID: 16502431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 11q terminal deletion and combined immunodeficiency (Jacobsen syndrome): Case report and literature review on immunodeficiency in Jacobsen syndrome.
    Blazina Š; Ihan A; Lovrečić L; Hovnik T
    Am J Med Genet A; 2016 Dec; 170(12):3237-3240. PubMed ID: 27605496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Jacobsen syndrome: Advances in our knowledge of phenotype and genotype.
    Favier R; Akshoomoff N; Mattson S; Grossfeld P
    Am J Med Genet C Semin Med Genet; 2015 Sep; 169(3):239-50. PubMed ID: 26285164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short stature and failure of pubertal development in thalassaemia major: evidence for hypothalamic neurosecretory dysfunction of growth hormone secretion and defective pituitary gonadotropin secretion.
    Roth C; Pekrun A; Bartz M; Jarry H; Eber S; Lakomek M; Schröter W
    Eur J Pediatr; 1997 Oct; 156(10):777-83. PubMed ID: 9365067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and endocrine characteristics in atypical and classical growth hormone insensitivity syndrome.
    Burren CP; Woods KA; Rose SJ; Tauber M; Price DA; Heinrich U; Gilli G; Razzaghy-Azar M; Al-Ashwal A; Crock PA; Rochiccioli P; Yordam N; Ranke MB; Chatelain PG; Preece MA; Rosenfeld RG; Savage MO
    Horm Res; 2001; 55(3):125-30. PubMed ID: 11549873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Partial deletion of the long arm of chromosome 11: ten Japanese children.
    Ono J; Hasegawa T; Sugama S; Sagehashi N; Hase Y; Oku K; Endo Y; Ohdo S; Ishikiriyama S; Tsukamoto H; Okada S
    Clin Genet; 1996 Dec; 50(6):474-8. PubMed ID: 9147876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth hormone and insulin-like growth factor I axis and growth of children with different sickle cell anemia haplotypes.
    Luporini SM; Bendit I; Manhani R; Bracco OL; Manzella L; Giannella-Neto D
    J Pediatr Hematol Oncol; 2001; 23(6):357-63. PubMed ID: 11563770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Safety and Efficacy of Growth Hormone Therapy by IGF-1 Z Score in Children with Short Stature.
    Liu HJ; Wang LH; Chen L
    Adv Ther; 2019 Sep; 36(9):2374-2383. PubMed ID: 31301056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. National Cooperative Growth Study substudy VI: the clinical utility of growth-hormone-binding protein, insulin-like growth factor I, and insulin-like growth factor-binding protein 3 measurements.
    Attie KM; Julius JR; Stoppani C; Rundle AC
    J Pediatr; 1997 Jul; 131(1 Pt 2):S56-60. PubMed ID: 9255230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional and total IGFBP3 for the assessment of disorders of the GH/IGF1 axis in children with chronic kidney disease, GH deficiency, or short stature after SGA status at birth.
    Büscher AK; Büscher R; Pridzun L; Langkamp M; Wachendorfer N; Hoyer PF; Ranke MB; Hauffa BP
    Eur J Endocrinol; 2012 May; 166(5):923-31. PubMed ID: 22318747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.